Racial disparities in the rate of same-admission cholecystectomy following biliary pancreatitis - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Disparities Among Racial Groups in Same-Hospital Admission Rates for Cholecystectomy After Biliary Pancreatitis

  • By

  • Yael Weisz

  • Brynne Ichiuji

  • Matthew Ashbrook

  • Anaar Siletz

  • Matthew Martin

  • Kenji Inaba

  • Kazuhide Matsushima

  • September 18, 2026

Share

Objective:

To examine practice patterns in the surgical treatment of mild and moderate biliary pancreatitis, focusing on racial disparities in same-admission cholecystectomy (SAC) rates.

Approach:
  • Study Design: Retrospective observational cohort study using the Healthcare Cost and Utilization Project National Inpatient Sample (HCUP NIS) from January 2016 to December 2021.
  • Patient Selection: Included adults aged 18 and older with acute biliary pancreatitis, excluding those with severe pancreatitis based on a modified BISAP score.
  • Data Analysis: Compared baseline characteristics and outcomes between patients undergoing SAC and those not undergoing SAC using statistical methods including Chi-square tests and Cox regression.
Key Findings:
  • Out of 482,705 patients with mild or moderate biliary pancreatitis, 59% underwent SAC.
  • SAC recipients were younger, more frequently female, and more often Hispanic compared to the no-SAC group.
  • Significant differences in SAC rates were observed based on hospital location, region, teaching status, insurance payer, and income quartile, with p-values indicating statistical significance.
Interpretation:

The study highlights disparities in SAC rates among different racial and demographic groups.

Limitations:
  • The study is retrospective and may be subject to biases inherent in observational data.
  • Data were limited to the HCUP NIS, which may not capture all relevant clinical variables.
Conclusion:

The findings indicate disparities in surgical treatment for biliary pancreatitis.

Original Source(s)

Related Content